Auris Health Recalls MONARCH Bronchoscopy Platform Due to Software Malfunction
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Auris Health, Inc. has issued a voluntary recall for 173 MONARCH Bronchoscopy Platforms due to a software issue that could cause unexpected robotic arm movement toward the patient.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on March 3, 2026 and geographically references Worldwide. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Auris Health, Inc. has initiated a voluntary recall of its MONARCH Platform used for bronchoscopy. The recall is driven by a software defect: if the application restarts after the patient-side selection is made but before the bronchoscope is loaded, the system re-initializes to a "patient-left" position. If the operator had previously selected the "patient-right" position, this software reset can lead to unanticipated robotic arm movement toward the patient's left side.
Which Products Are Affected
A total of 173 units are affected by this recall. The specific products include:
- Product Name: MONARCH Platform, Bronchoscopy
- Catalog Numbers: MON-000005-01, MON-000005-01R, MON-000006, MON-000006-RFB, MON-000008
- Software Versions: 2.2.2, 2.2.3, 2.2.4, 2.2.5, and 4.1.1
- UDI-DI: 10810068810803, 10810068810988
- Serial Numbers: 173 specific serial numbers are included in the recall (e.g., 110024, 120088, 120057, 120046, 120058, and others listed in the official report).
This recall affects distribution in Canada, China, Hong Kong, and the following U.S. states: AL, AZ, CA, CO, CT, DC, DE, FL, GA, ID, IL, IN, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NY, OH, OR, PA, SC, SD, TN, TX, VA, VT, WA, WI, and WV.
What You Should Do
This is a firm-initiated voluntary recall. Healthcare providers and facilities utilizing the MONARCH Platform should verify if their equipment is running the affected software versions (2.2.2 through 2.2.5 or 4.1.1). Users should follow any specific corrective instructions provided by Auris Health, Inc. regarding software updates or operational workarounds to prevent unanticipated arm movement.
Why This Matters
The software error creates a risk of unanticipated robotic arm positioning. This movement may result in the robotic arm making physical contact with the patient or the endotracheal tube, potentially compromising patient safety during a procedure.
Source
Information provided by the FDA under Recall Number Z-1383-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category